Researchers at the University of Helsinki have found that metformin can activate certain immune cells, making them better at spotting and attacking cancer. The findings, published in the Journal for ...

“Patient-derived models such as patient-derived organoid models have been used more widely in academics and industries offering more complex systems representing tumor heterogeneity and tumor ...

Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric ...

This specific tumor combination has been reported in very few cases. The patient was a 41-year-old woman who came to the hospital with lower abdominal pain and swelling that had persisted for ...

A multidisciplinary clinical team led by Professor Bernat Soria from the Institute of Bioengineering at the Miguel Hernández ...

Angus Chen covers all issues broadly related to cancer including drugs ... Research Programs (CDMRP), for which his consortium of patient and provider groups advocates. “No money for kidney ...

Research led at Dana-Farber in Boston by Jennifer Chan, MD, MPH, supports an FDA approval for cabozantinib for previously treated patients with advanced neuroendocrine tumors. Boston ...